Bakuchiol: Keep the Wrinkle Rating Beside the Claim

If you are considering a bakuchiol product, begin with the feature you want assessed. A wrinkle rating, a pigmentation measurement and a concern about facial fullness need different evidence. Keep the product information beside your current skin-care list before deciding whether to add anything.

What did the vehicle-controlled trial compare?

Khan and colleagues randomized 73 Chinese adults aged 32–60 to 0.5% bakuchiol lotion or the same vehicle without bakuchiol, twice daily for 84 days. Two participants were lost to follow-up. The mostly female sample was not selected for GLP-1 use. [1]

A vehicle is the formulation used to carry an ingredient. In this comparison, the control helps answer whether adding the ingredient changed the measured outcome. It does not compare every product sold under the ingredient's name.

Read the wrinkle result with its measurement

At day 84, the active group's global wrinkle rating had fallen 5.2% from baseline; the between-group comparison was significant (P=.023). This percentage describes a rating change, not a percentage of people whose wrinkles disappeared. [1]

When discussing the finding, keep the assessment name attached to the number. Ask what a change on that scale would mean for the feature you notice. A statistically significant comparison does not, on its own, tell you whether the difference would meet your expectations.

The trial did not compare bakuchiol with retinol or directly measure structural changes. Its abstract and discussion list some visit dates inconsistently with the methods and results, which report days 28, 56 and 84. Sytheon, now Hallstar, supplied funding and prepared both formulations; author affiliations included the company. [1]

Those details belong beside the result when weighing the paper. Avoid using it to settle a different question, such as which ingredient is best for you, without a relevant comparison and a review of your own skin.

Review what you already use

The American Academy of Dermatology recommends starting with sunscreen and moisturizer, then choosing a product for one remaining concern. For sunscreen, it specifies broad-spectrum protection, SPF 30 or higher, and water resistance, with reapplication every two hours outdoors. Adding several anti-aging products close together can irritate skin. [2]

Write a short list of your cleanser, moisturizer, sunscreen, prescription skin treatments and occasional products. Include how often you use each one. If a step stings or leaves your skin visibly irritated, describe that before discussing an addition.

You can ask: “This is what I use now, and this is the feature I want assessed. Does adding this product fit the plan, and how would we decide whether to continue?” Get instructions from the clinician managing a prescription before changing it to imitate a cosmetic study.

Keep the GLP-1 question specific

If you notice a facial change during treatment, record when it appeared and what else changed around that time. Bring the medicine list and the cosmetic list to the appointment. Ask who should assess the appearance concern and which questions belong with your GLP-1 prescriber.

For example, “I notice more visible lines around my eyes” gives the discussion a different starting point from “My cheeks seem less full.” Use the description that fits what you see. You do not need to diagnose the cause before asking for an assessment.

If an optional cosmetic purchase is appropriate, set a spending limit and ask how progress will be reviewed. Keep the product name, instructions and agreed review date together. A receipt can tell you when you bought it; it cannot substitute for the concern and outcome you intended to discuss.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.